시장보고서
상품코드
1866829

세계의 일회용 피하 주사기 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

Disposable Hypodermic Syringes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 일회용 피하 주사기 시장 규모는 2024년에 79억 8,500만 달러로 추정되며, 2025년부터 2031년까지 예측 기간 동안 CAGR 5.2%로 성장하여 2031년까지 112억 3,800만 달러로 확대될 것으로 예측됩니다.

본 보고서는 일회용 피하 주사기에 대한 최근 관세 조정 및 국제적인 전략적 대응 조치, 국경 간 산업 발자국, 자본 배분 패턴, 지역경제 상호의존성, 공급망 재구축에 대해 종합적으로 평가합니다.

일회용 피하 주사 바늘은 의료, 과학 연구, 수의학, 공중 보건 분야에서 널리 사용되는 기초 의료기기입니다. 주로 인간이나 동물의 피하, 근육 내 또는 정맥내 조직에 액체 약물을 투여하기 위해 설계되었으며, 체액이나 혈액 샘플을 채취하는 데에도 사용됩니다. 본 제품은 주사기 본체, 플런저, 고무 마개, 바늘로 구성되며, 의료용 폴리프로필렌(PP), 스테인리스 스틸 등 무독성, 무균 소재로 제조되는 것이 일반적입니다. 이를 통해 우수한 생체적합성과 작동 안전성을 보장합니다. 각 주사기는 출하 전에 엄격한 멸균 처리를 거쳐 1회 사용을 전제로 하며, 사용 후에는 교차 오염을 방지하기 위해 적절히 폐기해야 합니다.

일회용 피하 주사기는 백신 접종(예 : 독감 백신, COVID-19 백신), 만성질환 관리(예 : 당뇨병 환자의 인슐린 주사), 항생제 및 호르몬 요법, 수술 전/후 마취 투여, 체액 채취 및 검사에 널리 활용되고 있습니다. 실험실에서는 시료 채취 및 정밀한 액체 분주에도 일반적으로 사용됩니다. 수의학 분야에서는 가축과 반려동물의 백신 접종 및 치료에 필수적인 기구로 활용되고 있습니다.

2024년, 일회용 피하 주사기의 세계 판매량은 710억 개를 넘어섰고, 평균 공장 출하가격은 1,000개당 약 110달러였습니다.

북미 일회용 피하 주사기 시장은 선진화된 의료 인프라, 높은 만성질환 관리율, 광범위한 예방접종 프로그램 등에 힘입어 성숙한 시장으로 성장하고 있습니다. 미국과 캐나다에서는 제품 품질과 안전에 대한 엄격한 규제 기준이 유지되고 있으며, 이는 바늘의 안전 메커니즘과 친환경 소재에 대한 기술 혁신을 촉진하고 있습니다. 또한, 정부 주도의 예방접종 캠페인과 인슐린 의존성 당뇨병 환자가 많다는 점도 안정적인 수요에 기여하고 있습니다.

유럽의 일회용 피하주사바늘 시장은 탄탄한 공공 의료 시스템과 환자 안전에 대한 강한 관심에 힘입어 성장하고 있습니다. 독일, 프랑스, 영국 등의 국가는 침 찔림 사고를 감소시키는 안전 설계 주사바늘을 일찍이 도입한 국가입니다. 이 지역의 시장 성장은 지속적인 예방접종 활동, 고령화, 의료기기에 재생 가능하고 환경적으로 지속가능한 재료의 사용을 촉진하는 EU 지침의 영향도 받고 있습니다.

아시아태평양은 가장 빠르게 성장하는 시장으로 중국, 인도, 일본이 주요 견인차 역할을 하고 있습니다. 급속한 도시화, 의료 접근성 확대, COVID-19 백신 접종을 포함한 대규모 정부 주도의 예방접종 프로그램이 수요를 크게 증가시켰습니다. 또한, 중국과 인도에서 자국산 바늘 제조의 부상으로 제품의 가용성과 경제성이 향상되고 있는 반면, 일본은 고품질의 정밀하게 설계된 제품에 집중하고 있습니다.

라틴아메리카에서는 브라질, 멕시코 등의 국가에서 공공 예방접종 프로그램과 의료 접근성 향상으로 인해 수요가 증가하고 있습니다. 그러나 공립병원의 예산 제약과 일부 지역의 수입 의존도 등의 문제도 존재합니다. 해외 공급업체에 대한 의존도를 낮추기 위해 현지 생산에 대한 노력이 확대되고 있습니다.

중동 및 아프리카 시장은 의료 인프라 확충과 백신 접종 캠페인에 대한 정부 지출 증가에 힘입어 꾸준히 성장하고 있습니다. UAE와 사우디아라비아를 중심으로 한 걸프 국가들은 고급 의료기기에 집중하는 반면, 아프리카 국가들은 민관 협력 및 기부자 자금 지원 보건 프로그램을 통해 주사기 공급망을 점차 개선하고 있습니다.

이 보고서는 전 세계 일회용 피하 주사기 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

이 보고서는 일회용 피하 주사기의 시장 규모, 추정치 및 예측치를 판매량(백만 단위) 및 매출액(백만 달러)으로 제시하고, 2024년을 기준 연도, 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 예측 시장 규모를 제시합니다. 정량적, 정성적 분석을 통해 독자들이 일회용 피하 주사기 관련 사업/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 사업적 판단을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

  • BD
  • Terumo
  • Cardinal Health
  • Nipro Corp
  • Merit Medical
  • B. Braun
  • ICU Medical
  • Hindustan Syringes & Medical Devices
  • Feel Tech Bio
  • WEGO
  • Zhejiang Kindly Medical
  • Jiangxi Sansin
  • Anhui Hongyu Wuzhou
  • Shandong Qiaopai
  • Jiangsu Zhengkang
  • Henan Shuguang Jianshi
  • Jiangsu Jichun
  • Shengguang Group
  • Jiangxi Hongda
  • Shifeng Medical

유형별 부문

  • 기존 주사기
  • 안전 주사기

용도별 부문

  • 병원·진료소
  • 진단 검사실
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSM 25.11.27

자주 묻는 질문

  • 일회용 피하 주사기 시장 규모는 어떻게 예측되나요?
  • 2024년 일회용 피하 주사기의 세계 판매량은 얼마인가요?
  • 북미 일회용 피하 주사기 시장의 특징은 무엇인가요?
  • 유럽의 일회용 피하 주사기 시장은 어떤 요인으로 성장하고 있나요?
  • 아시아태평양 지역의 일회용 피하 주사기 시장 성장 요인은 무엇인가요?
  • 일회용 피하 주사기의 주요 용도는 무엇인가요?
  • 일회용 피하 주사기 시장의 주요 기업은 어디인가요?

The global market for Disposable Hypodermic Syringes was estimated to be worth US$ 7985 million in 2024 and is forecast to a readjusted size of US$ 11238 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Disposable Hypodermic Syringes cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A disposable hypodermic syringe is a fundamental medical device widely used in healthcare, scientific research, veterinary medicine, and public health. It is primarily designed to deliver liquid medications into the subcutaneous, intramuscular, or intravenous tissues of humans or animals and can also be used to draw bodily fluids or blood samples. The product consists of a barrel, plunger, rubber stopper, and needle, and is typically made from non-toxic, sterile materials such as medical-grade polypropylene (PP) and stainless steel, ensuring good biocompatibility and operational safety. Each syringe undergoes strict sterilization before leaving the factory, is intended for single use, and must be properly disposed of after use to prevent cross-contamination.

Disposable hypodermic syringes are widely applied in vaccine administration (e.g., influenza vaccine, COVID-19 vaccine), chronic disease management (e.g., insulin injection for diabetes patients), antibiotic and hormone therapies, preoperative and postoperative anesthetic administration, as well as in the extraction and testing of bodily fluids. In laboratories, they are also commonly used for sample extraction and precise liquid dispensing. In veterinary medicine, these syringes serve as essential tools for livestock and pet vaccination and treatment.

In 2024, the global sales of disposable hypodermic syringes exceeded 71 billion units, with an average ex-factory price of approximately $110 per thousand units.

The North American market for disposable hypodermic syringes is mature, driven by advanced healthcare infrastructure, high rates of chronic disease management, and widespread vaccination programs. The U.S. and Canada maintain strict regulatory standards for product quality and safety, which has encouraged innovation in needle safety mechanisms and eco-friendly materials. Additionally, government-led immunization campaigns and the prevalence of insulin-dependent diabetes patients contribute to steady demand.

Europe's disposable hypodermic syringe market is supported by robust public healthcare systems and strong emphasis on patient safety. Countries such as Germany, France, and the U.K. are early adopters of safety-engineered syringes to reduce needlestick injuries. The region's market growth is also influenced by ongoing vaccination drives, aging populations, and EU directives promoting the use of recyclable and environmentally sustainable materials in medical devices.

The Asia-Pacific region is the fastest-growing market, with China, India, and Japan as key drivers. Rapid urbanization, expanding healthcare access, and large-scale government immunization programs, including COVID-19 vaccination efforts, have significantly boosted demand. In addition, the rise of domestic syringe manufacturing in China and India has improved product affordability and availability, while Japan focuses on high-quality, precision-engineered products.

In Latin America, countries such as Brazil and Mexico are experiencing rising demand due to public vaccination programs and improved healthcare accessibility. However, the market faces challenges from budget constraints in public hospitals and dependence on imports in some regions. Local manufacturing initiatives are emerging to reduce reliance on foreign suppliers.

The Middle East & Africa market is growing steadily, supported by expanding healthcare infrastructure and increased government spending on vaccination campaigns. Gulf countries, led by the UAE and Saudi Arabia, focus on premium medical devices, while African nations are gradually improving syringe supply chains through public-private partnerships and donor-funded health programs.

This report aims to provide a comprehensive presentation of the global market for Disposable Hypodermic Syringes, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Disposable Hypodermic Syringes by region & country, by Type, and by Application.

The Disposable Hypodermic Syringes market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Disposable Hypodermic Syringes.

Market Segmentation

By Company

  • BD
  • Terumo
  • Cardinal Health
  • Nipro Corp
  • Merit Medical
  • B. Braun
  • ICU Medical
  • Hindustan Syringes & Medical Devices
  • Feel Tech Bio
  • WEGO
  • Zhejiang Kindly Medical
  • Jiangxi Sansin
  • Anhui Hongyu Wuzhou
  • Shandong Qiaopai
  • Jiangsu Zhengkang
  • Henan Shuguang Jianshi
  • Jiangsu Jichun
  • Shengguang Group
  • Jiangxi Hongda
  • Shifeng Medical

Segment by Type

  • Conventional Syringes
  • Safety Syringes

Segment by Application

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Disposable Hypodermic Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Disposable Hypodermic Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Disposable Hypodermic Syringes in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Disposable Hypodermic Syringes Product Introduction
  • 1.2 Global Disposable Hypodermic Syringes Market Size Forecast
    • 1.2.1 Global Disposable Hypodermic Syringes Sales Value (2020-2031)
    • 1.2.2 Global Disposable Hypodermic Syringes Sales Volume (2020-2031)
    • 1.2.3 Global Disposable Hypodermic Syringes Sales Price (2020-2031)
  • 1.3 Disposable Hypodermic Syringes Market Trends & Drivers
    • 1.3.1 Disposable Hypodermic Syringes Industry Trends
    • 1.3.2 Disposable Hypodermic Syringes Market Drivers & Opportunity
    • 1.3.3 Disposable Hypodermic Syringes Market Challenges
    • 1.3.4 Disposable Hypodermic Syringes Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Disposable Hypodermic Syringes Players Revenue Ranking (2024)
  • 2.2 Global Disposable Hypodermic Syringes Revenue by Company (2020-2025)
  • 2.3 Global Disposable Hypodermic Syringes Players Sales Volume Ranking (2024)
  • 2.4 Global Disposable Hypodermic Syringes Sales Volume by Company Players (2020-2025)
  • 2.5 Global Disposable Hypodermic Syringes Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Disposable Hypodermic Syringes Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Disposable Hypodermic Syringes Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Disposable Hypodermic Syringes
  • 2.9 Disposable Hypodermic Syringes Market Competitive Analysis
    • 2.9.1 Disposable Hypodermic Syringes Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Disposable Hypodermic Syringes Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disposable Hypodermic Syringes as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Conventional Syringes
    • 3.1.2 Safety Syringes
  • 3.2 Global Disposable Hypodermic Syringes Sales Value by Type
    • 3.2.1 Global Disposable Hypodermic Syringes Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Disposable Hypodermic Syringes Sales Value, by Type (2020-2031)
    • 3.2.3 Global Disposable Hypodermic Syringes Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Disposable Hypodermic Syringes Sales Volume by Type
    • 3.3.1 Global Disposable Hypodermic Syringes Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Disposable Hypodermic Syringes Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Disposable Hypodermic Syringes Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Disposable Hypodermic Syringes Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals and Clinics
    • 4.1.2 Diagnostic Laboratories
    • 4.1.3 Others
  • 4.2 Global Disposable Hypodermic Syringes Sales Value by Application
    • 4.2.1 Global Disposable Hypodermic Syringes Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Disposable Hypodermic Syringes Sales Value, by Application (2020-2031)
    • 4.2.3 Global Disposable Hypodermic Syringes Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Disposable Hypodermic Syringes Sales Volume by Application
    • 4.3.1 Global Disposable Hypodermic Syringes Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Disposable Hypodermic Syringes Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Disposable Hypodermic Syringes Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Disposable Hypodermic Syringes Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Disposable Hypodermic Syringes Sales Value by Region
    • 5.1.1 Global Disposable Hypodermic Syringes Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Disposable Hypodermic Syringes Sales Value by Region (2020-2025)
    • 5.1.3 Global Disposable Hypodermic Syringes Sales Value by Region (2026-2031)
    • 5.1.4 Global Disposable Hypodermic Syringes Sales Value by Region (%), (2020-2031)
  • 5.2 Global Disposable Hypodermic Syringes Sales Volume by Region
    • 5.2.1 Global Disposable Hypodermic Syringes Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Disposable Hypodermic Syringes Sales Volume by Region (2020-2025)
    • 5.2.3 Global Disposable Hypodermic Syringes Sales Volume by Region (2026-2031)
    • 5.2.4 Global Disposable Hypodermic Syringes Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Disposable Hypodermic Syringes Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 5.4.2 North America Disposable Hypodermic Syringes Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 5.5.2 Europe Disposable Hypodermic Syringes Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Disposable Hypodermic Syringes Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 5.7.2 South America Disposable Hypodermic Syringes Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Disposable Hypodermic Syringes Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Disposable Hypodermic Syringes Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Disposable Hypodermic Syringes Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Disposable Hypodermic Syringes Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.3.2 United States Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.4.2 Europe Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.5.2 China Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.6.2 Japan Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.7.2 South Korea Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Disposable Hypodermic Syringes Sales Value, 2020-2031
    • 6.9.2 India Disposable Hypodermic Syringes Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Disposable Hypodermic Syringes Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 BD
    • 7.1.1 BD Company Information
    • 7.1.2 BD Introduction and Business Overview
    • 7.1.3 BD Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 BD Disposable Hypodermic Syringes Product Offerings
    • 7.1.5 BD Recent Development
  • 7.2 Terumo
    • 7.2.1 Terumo Company Information
    • 7.2.2 Terumo Introduction and Business Overview
    • 7.2.3 Terumo Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Terumo Disposable Hypodermic Syringes Product Offerings
    • 7.2.5 Terumo Recent Development
  • 7.3 Cardinal Health
    • 7.3.1 Cardinal Health Company Information
    • 7.3.2 Cardinal Health Introduction and Business Overview
    • 7.3.3 Cardinal Health Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Cardinal Health Disposable Hypodermic Syringes Product Offerings
    • 7.3.5 Cardinal Health Recent Development
  • 7.4 Nipro Corp
    • 7.4.1 Nipro Corp Company Information
    • 7.4.2 Nipro Corp Introduction and Business Overview
    • 7.4.3 Nipro Corp Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Nipro Corp Disposable Hypodermic Syringes Product Offerings
    • 7.4.5 Nipro Corp Recent Development
  • 7.5 Merit Medical
    • 7.5.1 Merit Medical Company Information
    • 7.5.2 Merit Medical Introduction and Business Overview
    • 7.5.3 Merit Medical Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Merit Medical Disposable Hypodermic Syringes Product Offerings
    • 7.5.5 Merit Medical Recent Development
  • 7.6 B. Braun
    • 7.6.1 B. Braun Company Information
    • 7.6.2 B. Braun Introduction and Business Overview
    • 7.6.3 B. Braun Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 B. Braun Disposable Hypodermic Syringes Product Offerings
    • 7.6.5 B. Braun Recent Development
  • 7.7 ICU Medical
    • 7.7.1 ICU Medical Company Information
    • 7.7.2 ICU Medical Introduction and Business Overview
    • 7.7.3 ICU Medical Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 ICU Medical Disposable Hypodermic Syringes Product Offerings
    • 7.7.5 ICU Medical Recent Development
  • 7.8 Hindustan Syringes & Medical Devices
    • 7.8.1 Hindustan Syringes & Medical Devices Company Information
    • 7.8.2 Hindustan Syringes & Medical Devices Introduction and Business Overview
    • 7.8.3 Hindustan Syringes & Medical Devices Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Hindustan Syringes & Medical Devices Disposable Hypodermic Syringes Product Offerings
    • 7.8.5 Hindustan Syringes & Medical Devices Recent Development
  • 7.9 Feel Tech Bio
    • 7.9.1 Feel Tech Bio Company Information
    • 7.9.2 Feel Tech Bio Introduction and Business Overview
    • 7.9.3 Feel Tech Bio Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Feel Tech Bio Disposable Hypodermic Syringes Product Offerings
    • 7.9.5 Feel Tech Bio Recent Development
  • 7.10 WEGO
    • 7.10.1 WEGO Company Information
    • 7.10.2 WEGO Introduction and Business Overview
    • 7.10.3 WEGO Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 WEGO Disposable Hypodermic Syringes Product Offerings
    • 7.10.5 WEGO Recent Development
  • 7.11 Zhejiang Kindly Medical
    • 7.11.1 Zhejiang Kindly Medical Company Information
    • 7.11.2 Zhejiang Kindly Medical Introduction and Business Overview
    • 7.11.3 Zhejiang Kindly Medical Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Zhejiang Kindly Medical Disposable Hypodermic Syringes Product Offerings
    • 7.11.5 Zhejiang Kindly Medical Recent Development
  • 7.12 Jiangxi Sansin
    • 7.12.1 Jiangxi Sansin Company Information
    • 7.12.2 Jiangxi Sansin Introduction and Business Overview
    • 7.12.3 Jiangxi Sansin Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Jiangxi Sansin Disposable Hypodermic Syringes Product Offerings
    • 7.12.5 Jiangxi Sansin Recent Development
  • 7.13 Anhui Hongyu Wuzhou
    • 7.13.1 Anhui Hongyu Wuzhou Company Information
    • 7.13.2 Anhui Hongyu Wuzhou Introduction and Business Overview
    • 7.13.3 Anhui Hongyu Wuzhou Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Anhui Hongyu Wuzhou Disposable Hypodermic Syringes Product Offerings
    • 7.13.5 Anhui Hongyu Wuzhou Recent Development
  • 7.14 Shandong Qiaopai
    • 7.14.1 Shandong Qiaopai Company Information
    • 7.14.2 Shandong Qiaopai Introduction and Business Overview
    • 7.14.3 Shandong Qiaopai Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Shandong Qiaopai Disposable Hypodermic Syringes Product Offerings
    • 7.14.5 Shandong Qiaopai Recent Development
  • 7.15 Jiangsu Zhengkang
    • 7.15.1 Jiangsu Zhengkang Company Information
    • 7.15.2 Jiangsu Zhengkang Introduction and Business Overview
    • 7.15.3 Jiangsu Zhengkang Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Jiangsu Zhengkang Disposable Hypodermic Syringes Product Offerings
    • 7.15.5 Jiangsu Zhengkang Recent Development
  • 7.16 Henan Shuguang Jianshi
    • 7.16.1 Henan Shuguang Jianshi Company Information
    • 7.16.2 Henan Shuguang Jianshi Introduction and Business Overview
    • 7.16.3 Henan Shuguang Jianshi Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Henan Shuguang Jianshi Disposable Hypodermic Syringes Product Offerings
    • 7.16.5 Henan Shuguang Jianshi Recent Development
  • 7.17 Jiangsu Jichun
    • 7.17.1 Jiangsu Jichun Company Information
    • 7.17.2 Jiangsu Jichun Introduction and Business Overview
    • 7.17.3 Jiangsu Jichun Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Jiangsu Jichun Disposable Hypodermic Syringes Product Offerings
    • 7.17.5 Jiangsu Jichun Recent Development
  • 7.18 Shengguang Group
    • 7.18.1 Shengguang Group Company Information
    • 7.18.2 Shengguang Group Introduction and Business Overview
    • 7.18.3 Shengguang Group Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Shengguang Group Disposable Hypodermic Syringes Product Offerings
    • 7.18.5 Shengguang Group Recent Development
  • 7.19 Jiangxi Hongda
    • 7.19.1 Jiangxi Hongda Company Information
    • 7.19.2 Jiangxi Hongda Introduction and Business Overview
    • 7.19.3 Jiangxi Hongda Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Jiangxi Hongda Disposable Hypodermic Syringes Product Offerings
    • 7.19.5 Jiangxi Hongda Recent Development
  • 7.20 Shifeng Medical
    • 7.20.1 Shifeng Medical Company Information
    • 7.20.2 Shifeng Medical Introduction and Business Overview
    • 7.20.3 Shifeng Medical Disposable Hypodermic Syringes Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Shifeng Medical Disposable Hypodermic Syringes Product Offerings
    • 7.20.5 Shifeng Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Disposable Hypodermic Syringes Industrial Chain
  • 8.2 Disposable Hypodermic Syringes Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Disposable Hypodermic Syringes Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Disposable Hypodermic Syringes Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제